These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 34558234)
21. Nanoparticle-based local antimicrobial drug delivery. Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377 [TBL] [Abstract][Full Text] [Related]
22. Factors pivotal for designing of nanoantimicrobials: an exposition. Jamil B; Imran M Crit Rev Microbiol; 2018 Feb; 44(1):79-94. PubMed ID: 28421881 [TBL] [Abstract][Full Text] [Related]
23. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Smith AW Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314 [TBL] [Abstract][Full Text] [Related]
24. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Kester JC; Fortune SM Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927 [TBL] [Abstract][Full Text] [Related]
25. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles. Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979 [TBL] [Abstract][Full Text] [Related]
26. New approaches to the treatment of biofilm-related infections. Wilkins M; Hall-Stoodley L; Allan RN; Faust SN J Infect; 2014 Nov; 69 Suppl 1():S47-52. PubMed ID: 25240819 [TBL] [Abstract][Full Text] [Related]
27. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. Mahmoudi M; Serpooshan V ACS Nano; 2012 Mar; 6(3):2656-64. PubMed ID: 22397679 [TBL] [Abstract][Full Text] [Related]
28. The challenge of treating biofilm-associated bacterial infections. del Pozo JL; Patel R Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551 [TBL] [Abstract][Full Text] [Related]
34. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection? Zhang L; Liang E; Cheng Y; Mahmood T; Ge F; Zhou K; Bao M; Lv L; Li L; Yi J; Lu C; Tan Y Biomed Pharmacother; 2020 Aug; 128():110184. PubMed ID: 32450528 [TBL] [Abstract][Full Text] [Related]
35. In vitro antibiofilm and anti-adhesion effects of magnesium oxide nanoparticles against antibiotic resistant bacteria. Hayat S; Muzammil S; Rasool MH; Nisar Z; Hussain SZ; Sabri AN; Jamil S Microbiol Immunol; 2018 Apr; 62(4):211-220. PubMed ID: 29405384 [TBL] [Abstract][Full Text] [Related]
36. Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections. Wang X; Wang D; Lu H; Wang X; Wang X; Su J; Xia G Small; 2024 Mar; 20(10):e2305988. PubMed ID: 38178276 [TBL] [Abstract][Full Text] [Related]
37. Combatting antibiotic-resistant bacteria using nanomaterials. Gupta A; Mumtaz S; Li CH; Hussain I; Rotello VM Chem Soc Rev; 2019 Jan; 48(2):415-427. PubMed ID: 30462112 [TBL] [Abstract][Full Text] [Related]
38. Supramolecular Antibacterial Materials for Combatting Antibiotic Resistance. Li X; Bai H; Yang Y; Yoon J; Wang S; Zhang X Adv Mater; 2019 Feb; 31(5):e1805092. PubMed ID: 30536445 [TBL] [Abstract][Full Text] [Related]
39. Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms. Yan J; Bassler BL Cell Host Microbe; 2019 Jul; 26(1):15-21. PubMed ID: 31295420 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms. Luo Y; Yang Q; Zhang D; Yan W J Microbiol Biotechnol; 2021 Jan; 31(1):1-7. PubMed ID: 33323672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]